TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27133000

Group type: EXPERIMENTAL
Intervention: Standard-of-care therapy with video models
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard-of-care therapy without videos
Number of subjects: 28
Study: 25412614

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Medical Treatment Only (MTO)
Number of subjects: 1152
Study: 23314179

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quarter prone position
Number of subjects: 30

Group type: COMPARATOR
Intervention: Spontaneously breathing infants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ventilated infants
Number of subjects: 30
Study: 20869206

Group type: EXPERIMENTAL
Intervention: Spaghetti with 10% Barley Balance (BB)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Spaghetti with Glucagel (GG)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Spaghetti with increasing concentrations of Barley Balance (BB)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (spaghetti without β-glucan)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (glucose reference food)
Number of subjects: 9
Study: 19938897

Group type: EXPERIMENTAL
Intervention: Fampridine-SR (10 mg twice daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fampridine-SR (30 mg twice daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg on treatment day 5)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 17122715

Group type: EXPERIMENTAL
Intervention: General antidepressant requests
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Brand-specific antidepressant requests
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Antidepressant medication requests
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Depression history taking
Number of subjects: 152
Study: 15301041

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate (TU) 40 mg daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intramuscular depot sustanon 50 (SUS), 4 weekly
Number of subjects: 14

Group type: COMPARATOR
Intervention: Run-in and wash-out periods
Number of subjects: 14
Study: 11716062

Group type: EXPERIMENTAL
Intervention: Informed condition (participants were told the task required inference from premise pairs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uninformed condition (participants were told to learn pairs by trial and error)
Number of subjects: 0
Study: 9444731

Group type: EXPERIMENTAL
Intervention: Simulated hotline calls (students)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Simulated hotline calls (mothers)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Simulated hotline calls (students and mothers)
Number of subjects: 196
Study: 7862838

Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 2643606

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) for meniscal lesions
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) for anterior cruciate ligament (ACL) tears
Number of subjects: 50
Study: 5036880

Group type: EXPERIMENTAL
Intervention: Vagotomy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (pre-vagotomy)
Number of subjects: 33
Study: 30919407

Group type: EXPERIMENTAL
Intervention: ASN002 20 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ASN002 40 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ASN002 80 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29175810

Group type: EXPERIMENTAL
Intervention: Web-based nutrition education intervention
Number of subjects: 900

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 900
Study: 25305090

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg loading dose (LD)/90 mg twice-daily maintenance dose (MD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel 600 mg LD/75 mg once-daily MD
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 40
Study: 23870441

Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) intervention
Number of subjects: 593

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 593
Study: 20683244

Group type: EXPERIMENTAL
Intervention: artesunate-mefloquine
Number of subjects: 109

Group type: COMPARATOR
Intervention: mefloquine
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine
Number of subjects: 109

Group type: COMPARATOR
Intervention: amodiaquine-artesunate
Number of subjects: 109
Study: 19344028

Group type: EXPERIMENTAL
Intervention: Resorbable membrane (Bio-Gide) applied over the grafted sinus
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control side (uncovered graft)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Resorbable membrane (Bio-Gide)
Number of subjects: 6
Study: 17143302

Group type: EXPERIMENTAL
Intervention: hGH 500 microg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15163693

Group type: EXPERIMENTAL
Intervention: Williams syndrome (WS) group
Number of subjects: 43

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 43
Study: 11339453

Group type: EXPERIMENTAL
Intervention: SMAR(X)T
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard PVC control
Number of subjects: 80
Study: 9389293

Group type: EXPERIMENTAL
Intervention: Capsaicin 10 microg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Capsaicin 100 microg
Number of subjects: 10
Study: 8193441

Group type: EXPERIMENTAL
Intervention: McGill Pain Questionnaire
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Brief pain diary
Number of subjects: 54

Group type: COMPARATOR
Intervention: Checklist of foods consumed (Control)
Number of subjects: 54
Study: 3630890

Group type: EXPERIMENTAL
Intervention: Type A behavioral counseling (4.5 years followed by 1 year of no counseling)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Type A behavioral counseling (1 year)
Number of subjects: 289
Study: 29954374

Group type: EXPERIMENTAL
Intervention: Low tocotrienol (430 mg tocotrienol/day from DeltaGold 70 containing 300 mg tocotrienol)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: High tocotrienol (860 mg tocotrienol/day from DeltaGold 70 containing 600 mg tocotrienol)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo (430 mg olive oil/day)
Number of subjects: 89
Study: 27363723

Group type: EXPERIMENTAL
Intervention: Steroid-releasing implant
Number of subjects: 80
Study: 25917008

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Exposure Therapy (ET)
Number of subjects: 87
Study: 24351999

Group type: EXPERIMENTAL
Intervention: PLISSIT model sexual health enhancement program (4 sessions, 90 minutes each)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (received intervention post-experiment)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: PLISSIT model sexual health enhancement program
Number of subjects: 43
Study: 22147094

Group type: EXPERIMENTAL
Intervention: Levothyroxine (L-T4)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 19505297

Group type: EXPERIMENTAL
Intervention: Prevention protocol applied to overweight children, including up to three counselling sessions for parents
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study: 17216745

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine (PPA) 50 mg twice daily for seven days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 12628617

Group type: EXPERIMENTAL
Intervention: Piracetam (4.8 g/day)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba (120 mg/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 10711582

Group type: EXPERIMENTAL
Intervention: HIV‐risk reduction (HIV‐RR) intervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Health‐promotion control group
Number of subjects: 102
Study: 9398896

Group type: EXPERIMENTAL
Intervention: Eradication therapy (antibiotics)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 1593661

Group type: EXPERIMENTAL
Intervention: Enriched tapering and aftercare assistance program (available to 58 clients)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Written materials only (received by 56 clients)
Number of subjects: 114
Study: 6379122

Group type: COMPARATOR
Intervention: Chemotherapy alone (MVPP)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Chemotherapy followed by radiotherapy (MVPP + radiotherapy)
Number of subjects: 56
Study: 31265100

Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5 mg
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5/5 mg
Number of subjects: 698

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 698
Study: 28429147

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg/day for 15 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cumulative docetaxel exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age (younger men 55-68 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Current and ex-smokers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mood status
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haemoglobin levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Somnolence and muscle fatigue
Number of subjects: 0
Study: 28929697

Group type: EXPERIMENTAL
Intervention: Berberine 300 mg (tid) in addition to general therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: General therapy according to the latest guidelines
Number of subjects: 120
Study: 25041326

Group type: COMPARATOR
Intervention: Chemonucleolysis only (oxygen‐ozone combined with collagenase)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Chemonucleolysis combined with psoas compartment block (PCB)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Chemonucleolysis combined with PCB (Group B)
Number of subjects: 192
Study: 22112606

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Ritonavir‐boosted protease inhibitor (PI/r)
Number of subjects: 86
Study: 19528867

Group type: EXPERIMENTAL
Intervention: Heavy Resistance Exercise (HRE) protocol - parallel back squats at 40, 50, 60, and 80% of 1-repetition maximum after dynamic stretches
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control treatment - dynamic stretches only
Number of subjects: 10
Study: 17558827

Group type: EXPERIMENTAL
Intervention: Bupropion 300 mg/day with Cognitive Behavioral Therapy (CBT)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Bupropion 300 mg/day with Supportive Therapy (ST)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo with Cognitive Behavioral Therapy (CBT)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo with Supportive Therapy (ST)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Medication compliance
Number of subjects: 154
Study: 15366592

Group type: EXPERIMENTAL
Intervention: Integrative Chinese and Western medicine (ICWM) with Kangmin Xiaoban Yin for 7-10 days
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Integrative Chinese and Western medicine (ICWM)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (Western routine therapy)
Number of subjects: 176
Study: 11464427

Group type: EXPERIMENTAL
Intervention: Telephone counseling delivered by trained counselors (HOPP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Point-of-service intervention delivered by providers and staff (STORK)
Number of subjects: 0
Study: 9893769

Group type: EXPERIMENTAL
Intervention: 6 micrograms formoterol fumarate
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 12 micrograms formoterol fumarate
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 24 micrograms formoterol fumarate
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 48 micrograms formoterol fumarate
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 7992905

Group type: COMPARATOR
Intervention: Intrathecal fentanyl 0 micrograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intrathecal fentanyl 5 micrograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intrathecal fentanyl 10 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 20 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 40 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 50 micrograms
Number of subjects: 0
Study: 3051508

Group type: EXPERIMENTAL
Intervention: Amoxycillin + Erdosteine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Amoxycillin alone
Number of subjects: 24
Study: 4888877

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 mug.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Isoprenaline sulphate 1,000 mug.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Orciprenaline sulphate 1,500 mug.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31087164

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 60

Group type: COMPARATOR
Intervention: X-ray guidance
Number of subjects: 60
Study: 28105520

Group type: EXPERIMENTAL
Intervention: Patients with DSPN
Number of subjects: 48
Study: 25586870

Group type: EXPERIMENTAL
Intervention: Minimal additions to consent for standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-depth research consent
Number of subjects: 0

Group type: COMPARATOR
Intervention: No research consent
Number of subjects: 0
Study: 22695137

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 49

Group type: COMPARATOR
Intervention: Flexibility training
Number of subjects: 49
Study: 21462725

Group type: EXPERIMENTAL
Intervention: Diabetes self-management education (DSME) plus access to a nurse case manager (NCM)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Diabetes self-management education (DSME) only
Number of subjects: 165
Study: 19394478

Group type: EXPERIMENTAL
Intervention: Diet records
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Arizona Food Frequency Questionnaire
Number of subjects: 244

Group type: COMPARATOR
Intervention: Diet records and Arizona Food Frequency Questionnaire
Number of subjects: 244
Study: 12963552

Group type: EXPERIMENTAL
Intervention: Children with TBI
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy matched controls
Number of subjects: 36
Study: 11121627

Group type: EXPERIMENTAL
Intervention: Biafine
Number of subjects: 172

Group type: COMPARATOR
Intervention: Best Supportive Care (BSC)
Number of subjects: 172
Study: 9074535

Group type: EXPERIMENTAL
Intervention: Metoprolol (50 mg orally 12 hr and 1 hr before the study)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoprolol (50 mg orally 12 hr and 1 hr before the study) with dipyridamole
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control conditions (no metoprolol)
Number of subjects: 10
Study: 8189215

Group type: EXPERIMENTAL
Intervention: Contextual information provided before or immediately after seeing the film
Number of subjects: 185

Group type: COMPARATOR
Intervention: Contextual information provided after a week's retention interval
Number of subjects: 185
Study: 2870216

Group type: EXPERIMENTAL
Intervention: 0.1% Metipranolol
Number of subjects: 0
Study: 31748300

Group type: EXPERIMENTAL
Intervention: Home-based music programme plus standard care (SC)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Home-based reading programme plus standard care (SC)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 495
Study: 29411166

Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin (PRF) as a socket plug
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Plaster of Paris (POP) as bone substitute with PRF
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group with figure of eight suture only
Number of subjects: 48
Study: 27756286

Group type: EXPERIMENTAL
Intervention: 360° feedback from peers, standardized patients (SPs), and a trainer during communication skills training (CST)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Feedback by standardized patients (SPs)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Feedback by trainer
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Feedback by colleagues
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Theoretical introduction
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Memory card
Number of subjects: 34
Study: 24827123

Group type: COMPARATOR
Intervention: ABVD (8 cycles)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: BEACOPP (4 escalated cycles ≥ 4 baseline)
Number of subjects: 150
Study: 22541840

Group type: EXPERIMENTAL
Intervention: Losartan Potassium Tablets 50 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cozaar® Tablets 50 mg
Number of subjects: 60
Study: 19271158

Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-course radiotherapy (5×5 Gy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined radiochemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study: 17526461

Group type: EXPERIMENTAL
Intervention: MAOx (1.2 g)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Vitamins C and E
Number of subjects: 79
Study: 12948801

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Hypnotic treatment (zolpidem, triazolam, zopiclone, brotizolam)
Number of subjects: 47
Study: 11153594

Group type: EXPERIMENTAL
Intervention: Passive mandibular advancement
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Voluntary mandibular advancement
Number of subjects: 10

Group type: COMPARATOR
Intervention: Resting mandibular position
Number of subjects: 10
Study: 9356866

Group type: EXPERIMENTAL
Intervention: misoprostol (800 micrograms/day)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: silymarin (210 mg/day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: no drug treatment (control group)
Number of subjects: 52
Study: 8222746

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (2 mg/ml) ear drops twice daily for 7 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combined antibiotic (oxytetracycline 5 mg/ml, polymyxin B 10,000 units/ml, hydrocortisone 15 mg/ml) ear drops twice daily for 7 days
Number of subjects: 30
Study: 3511930

Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg slow release tablets once daily for at least 2 weeks, plus 15 mg i.v. shortly before anaesthesia)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (tablets and saline)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metoprolol and Placebo
Number of subjects: 30
Study: 31311102

Group type: EXPERIMENTAL
Intervention: Meal protein content at 11% kcal protein
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Meal protein content at 23% kcal protein
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Meal protein content at 31% kcal protein
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Women taking OCP
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Women without OCP
Number of subjects: 21
Study: 29350710

Group type: EXPERIMENTAL
Intervention: Structured strength training program introduced during hospitalization and continued for six weeks after release
Number of subjects: 37
Study: 27927270

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Endurance-strength training
Number of subjects: 44
Study: 23856201

Group type: COMPARATOR
Intervention: CABG alone
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: CABG plus downsizing mitral ring annuloplasty
Number of subjects: 31
Study: 22588156

Group type: EXPERIMENTAL
Intervention: Tasisulam sodium (LY573636 sodium) administered as a 2-hour infusion every 21 days at a Cmax target dose of 420 µg/ml
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tasisulam sodium (LY573636 sodium) administered at a lower Cmax target dose of 380 µg/ml
Number of subjects: 32
Study: 20209303

Group type: EXPERIMENTAL
Intervention: Study group (received instructions at all visits)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (received instructions only at the first visit)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Study group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 18716159

Group type: EXPERIMENTAL
Intervention: 50 mg/d quercetin for 2 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 100 mg/d quercetin for 2 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 150 mg/d quercetin for 2 weeks
Number of subjects: 35
Study: 15943544

Group type: EXPERIMENTAL
Intervention: Transdermal methylphenidate (MPH) 12.5 cm²
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Transdermal methylphenidate (MPH) 25.0 cm²
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Transdermal methylphenidate (MPH) 37.5 cm²
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Behavior modification (BMOD)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combined treatment (MPH + BMOD)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 12801361

Group type: COMPARATOR
Intervention: Miconazole (Daktarin(R) gel oral)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gel of Punica granatum Linné (pomegranate)
Number of subjects: 60
Study: 10591258

Group type: EXPERIMENTAL
Intervention: Contact laser ablation of the prostate (CLAP) using Nd:YAG laser treatment
Number of subjects: 37

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Contact laser ablation of the prostate (CLAP)
Number of subjects: 37